BRIAN BEACH: Open Payments
NPI 1821792854 · CHUBBUCK, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $135 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $28 |
| ABBVIE INC. | 1 | $26 |
Products named: QULIPTA, GVOKE HYPOPEN, RECORLEV, Rybelsus, Wegovy.
Industry payments across ID — which companies pay providers there.
